In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach
In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach
Vaishali Chandel,Sibi Raj,B. Rathi,Dhruv Kumar
2020
71 Citations
TLDR
The findings suggest that these compounds can be used as potential inhibitors against COVID-19 Main Protease, which could be helpful in inhibiting the propagation of the Novel Coronavirus (CO VID-19).